CASI Pharmaceuticals, Inc. Business Finance Contracts & Agreements

47 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Equity Transfer Agreement between CASI Biopharmaceuticals (Wuxi) Co., Ltd. and Shenzhen Jiadao Gongcheng Equity Investment Fund (Limited Partnership) dated September 22, 2022
Investment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2022
Commercial Pledge Agreement between the Registrant and East West Bank, dated May 23, 2022
Pledge Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2022
Commercial Security Agreement between the Registrant and East West Bank, dated May 23, 2022
Security Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2022
Business Loan Agreement between the Registrant and East West Bank, dated May 23, 2022
Loan Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2022
Promissory Note issued by the Registrant to East West Bank, dated May 23, 2022
Note Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2022
Common Stock Sales Agreement (the Sales Agreement) by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated October 29, 2021
Stock Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2021
Description of Common Stock
Stock Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2021
Investment Agreement by and between Juventas Cell Therapy Ltd and CASI Biopharmaceuticals (WUXI) Co., Ltd. effective as of September 22, 2020
Investment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2020
Contract for Assignment of the Right to the Use of the State-owned Construction Land (no. 3202842019CR0019) dated November 15, 2019
Assignment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2020
Description of Common Stock
Stock Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2020
Investment Agreement in respect of Juventas Cell Therapy Ltd. executed June 15, 2019
Investment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2019
Amendment No. 1 to Common Stock Sales Agreement by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated July 19, 2019
Stock Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2019
Shareholders Agreement, dated November 16, 2018, between CASI Pharmaceuticals, Inc. and Wuxi Jintou Huicun Investment Enterprise (Limited Partnership)
Investment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2019
Form of Securities Purchase Agreement
Purchase Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2018
Form of Warrant
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2018
Asset Purchase Agreement, dated as of January 26, 2018, by and between CASI Pharmaceuticals, Inc. and Sandoz Inc
Purchase Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2018
Form of Securities Purchase Agreement
Purchase Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2018
Form of Warrant
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2018
Common Stock Sales Agreement (the Sales Agreement) by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated February 23, 2018
Stock Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2018
Third Amendment to Secured Promissory Note, dated as of December 20, 2017, by and between the Company and Talon Therapeutics, Inc
Note Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2017
Form of Stock Purchase Agreement
Stock Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2017
Form of Wainwright Warrant
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2017
Form of Common Stock Purchase Warrant
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2017
SECOND AMENDMENT TO SECURED PROMISSORY NOTE
Note Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2016
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2015
FIRST AMENDMENT TO SECURED PROMISSORY NOTE
Note Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2015
Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AGREEMENT
Exchange Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2014
Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AGREEMENT
Exchange Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2014
Confidential Materials omitted andfiled separately with the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AGREEMENT
Exchange Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
CA
2014
INVESTMENT AGREEMENT
Investment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2014
INVESTMENT AGREEMENT
Investment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2014
SECURED PROMISSORY NOTE
Note Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2014
CERTIFICATE OF DESIGNATIONS OF series A preferred stock Of CASIPHARMACEUTICALS, INC.
Stock Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2014
FORM OF COMMON STOCK PURCHASE WARRANT entremed,inc.
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2013
FORM OF COMMON STOCK PURCHASE WARRANT entremed,inc.
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2013
CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2012
STANDBY EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2011
THISEXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIALTREATMENT REQUEST PURSUANT TO RULE 24b-2. REDACTEDMATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY...
Exchange Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2010
FORMOF COMMONSTOCK PURCHASE WARRANT ENTREMED,INC.
Warrant Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2010
PROMISSORY NOTE
Note Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2007